… In conclusion, relative effects of novel diabetes drugs are preserved across baseline
cardiovascular risk, whereas absolute benefits increase in those at high cardiovascular risk, …

… Moreover, a previous meta-analysis suggested that there were no significant differences
in … lowering drugs and the risk of cardiovascular or all-cause mortalities.20 The meta-regression …

… Multiple linear regression analysis indicated that angiotensin-converting enzyme (ACE) …
pressure, treatment duration, and the type of diabetes or stage of nephropathy, as well as study …

… de la diabetes manifiesta del tipo 2. La prediabetes está asociada con un mayor riesgo de
enfermedad cardiovascular, la cual es independiente al desarrollo de la diabetes. Éste meta …

… to treatments involving sulfonylureas, drugs associated with increased … A meta-regression
analysis was used to evaluate … With the introduction of new antidiabetic drugs, the use of …

… Drugs Advisory Committee of the US Food and Drug Administration concluded that A1C
should be the primary outcome variable for diabetes drugs and … with early diabetes, based on a …

… by drug class and an additional interaction term of drug class … 5 studies per drug class in
each meta‐regression analysis to … conducted additional meta‐regression analyses excluding …

… HF risks in placebo-controlled trials were similar to those from published meta-analyses of
trials controlling for both active drugs and placebo. Therefore the HF risks of active drugs are …

… Metformin is well established as a drug therapy in diabetes. … review and meta-analysis with
meta-regression our principal … metformin compared to other antidiabetic drugs or placebo; (ii) …

… The effect of diabetes education on glycemic control and the … a meta-analysis of randomized
controlled trials of diabetes … Additionally, we used meta-regression to analyze which …